Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT03155061	TitleStudy of ONO-4578 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors	Fase Fase 1	Date Added 2017-05-16	Ubicación Japón	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas ONO-4538, ONO-4578, Opdivo	Etiquetas MSS/ MMRp
NCT ID NCT02925234	TitleProtocolo de redescubrimiento de fármacos (ensayo DRUP)	Fase Fase 2	Date Added 2016-10-05	Ubicación Países Bajos	Prior IO Allowed Sí	CRC-directed No	Status Reclutamiento	Drogas Abemaciclib, afatinib, Alectinib, Alpelisib, Atezolizumab and Bevacizumab, Axitinib, Cabozantinib, Crizotinib, Dabrafenib, Dabrafenib and trametinib, Dacomitinib, durvalumab, Entrectinib, Erdafitinib, Erlotinib, Ipilimumab and nivolumab, Lenvatinib, lorlatinib, Nilotinib, Nivolumab, Olaparib, palbociclib, panitumumab, Pembrolizumab, Regorafenib, ribociclib, Rucaparib, Sunitinib, Talazoparib, Trametinib, Trastuzumab and Pertuzumab (combination treatment), Vemurafenib and Cobimetinib (combination treatment), Vismodegib	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04085185	TitleEstudio de evaluación de la seguridad, tolerabilidad y eficacia inicial de IBI110 en sujetos con tumores malignos avanzados.	Fase Fase 1	Date Added 2019-09-11	Ubicación China	Prior IO Allowed Sí	CRC-directed No	Status Reclutamiento	Drogas IBI110, IBI110+ Sintilimab, IBI110, Sintilinab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT02617277	TitleSafety, Tolerability and Pharmacokinetics of AZD1775 (Adavosertib) Plus MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumours	Fase Fase 1	Date Added 2015-11-30	Ubicación Colorado, United States Florida, United States Tennessee, United States	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas AZD1775, MEDI4736	Etiquetas MSS/ MMRp
NCT ID NCT04550897	TitleA Phase I/II Study With BM7PE Immunotoxin in Colorectal Cancer Patients	Fase Fase 1	Date Added 2020-09-16	Ubicación Noruega	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas BM7PE	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03368963	TitleTAS102 in Combination With NAL-IRI in Advanced GI Cancers	Fase Phase 1, Phase 2	Date Added 2017-12-11	Ubicación Georgia, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas Nanoliposomal Irinotecan, Trifluridine and Tipiracil Hydrochloride	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05291156	TitleCAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy	Fase Fase 2	Date Added 2022-03-22	Ubicación Italia	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas Avelumab, cetuximab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03476681	TitleStudy of NEO-201 in Solid Tumors Expansion Cohorts	Fase Phase 1, Phase 2	Date Added 2018-03-26	Ubicación Maryland, United States Virginia, United States	Prior IO Allowed Sí	CRC-directed No	Status Reclutamiento	Drogas NEO-201 in combination with pembrolizumab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID VAPER	TitleA study looking at using a vaccine and chemotherapy to treat advanced cancer	Fase Fase 1	Date Added 2015-11-17	Ubicación	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas Celecoxib, Cyclophosphamide, imiquimod, vaccine	Etiquetas MSS/ MMRp
NCT ID NCT03502733	TitleTesting the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma	Fase Fase 1	Date Added 2018-04-19	Ubicación Maryland, United States Texas, United States	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas Copanlisib, Ipilimumab, Nivolumab, Aliqopa, Opdivo	Etiquetas MSS/ MMRp

Showing 91 to 100 of 299 entries